Author's Reply: ``Use of biologics for the management of Crohn's disease''
Dig Liver Dis
.
2023 Jul;55(7):990.
doi: 10.1016/j.dld.2023.04.005.
Epub 2023 Jun 1.
Authors
Stefanos Bonovas
1
,
Fabio Salvatore Macaluso
2
,
Daniele Piovani
1
,
Claudio Papi
3
,
Ambrogio Orlando
4
,
Alessandro Armuzzi
5
Affiliations
1
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
2
Inflammatory bowel disease Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy. Electronic address: fsmacaluso@gmail.com.
3
Inflammatory bowel disease Unit, "San Filippo Neri" Hospital, Rome, Italy.
4
Inflammatory bowel disease Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy.
5
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. Electronic address: alessandro.armuzzi@hunimed.eu.
PMID:
37380281
DOI:
10.1016/j.dld.2023.04.005
No abstract available
Publication types
Letter
Comment
MeSH terms
Biological Products* / therapeutic use
Crohn Disease* / drug therapy
Humans
Substances
Biological Products